EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ZBTB4 Deficiency Exacerbates DSS-Induced Colitis Through Activating NF-κB Pathway

Xinyi Peng, Genglin Guo, Songyu Li, Songyao Sun, Cong Ouyang, Jiajun Cui iD

Cells · 18.05.2026 · 15 (10) · 929

DOI: 10.3390/cells15100929 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 18.05.2026. Verfasst von Xinyi Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Translational Medicine, Yichun University, Yichun 336000, China. Hauptthemen laut MEDLINE: NF-kappa B, Colitis, Signal Transduction, Transcription Factors. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel diseases, particularly ulcerative colitis (UC), are chronic relapsing inflammatory disorders with limited therapeutic options. The zinc-finger transcription factor ZBTB4 has been implicated in the initiation and progression of cancer, but its role in UC remains unknown. Here, we found that ZBTB4 deficiency exacerbates dextran sulfate sodium (DSS)-induced colitis in C57BL/6J male mice. Compared with the wild type, ZBTB4 deficiency increases weight loss, colon shortening and proinflammatory cytokine production. RNA-seq analysis revealed that ZBTB4 deficiency enhances Serpine1 expression and activates the NF-κB pathway. NF-κB inhibition by JSH-23 alleviated the effect of ZBTB4 deficiency on DSS-induced colitis. These results imply the protective role of ZBTB4 in UC. Through an integrated drug screening, we identified a natural sesquiterpene lactone, handelin, as a potential compound to enhance ZBTB4 expression in NCM460 cells. Handelin administration relieved colitis in wild-type mice but produced no effect in ZBTB4 knockout mice, demonstrating that its anti-colitic effect depends on ZBTB4 expression. Collectively, our results indicate the key role of ZBTB4 in UC and ZBTB4 agonists may serve as a novel approach for UC treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BColitisSignal TransductionTranscription FactorsAnimalsDextran SulfateMaleMice, Inbred C57BLMiceMice, KnockoutColitis, UlcerativeHumans

Stichwörter der Autor:innen

NF-κBSerpine1ZBTB4handelininflammationulcerative colitis

Substanzen

Dextran SulfateNF-kappa BTranscription Factors

Autor:innen und Institutionen

  • The Center for Translational Medicine, Yichun University, Yichun 336000, China.
  • The Department of Biochemistry, School of Basic Medical Sciences, Yichun University, Yichun 336000, China.

ORCID-Profile: Jiajun Cui

Förderung

  • National Natural Science Foundation of China
  • Jiangxi Provincial Natural Science Foundation

Zitieren

APA

Peng, X., Guo, G., Li, S., Sun, S., Ouyang, C., & Cui, J. (2026). ZBTB4 Deficiency Exacerbates DSS-Induced Colitis Through Activating NF-κB Pathway. Cells, 15(10), 929. https://doi.org/10.3390/cells15100929

Vancouver

Peng X, Guo G, Li S, Sun S, Ouyang C, Cui J. ZBTB4 Deficiency Exacerbates DSS-Induced Colitis Through Activating NF-κB Pathway. Cells. 2026;15(10):929. doi:10.3390/cells15100929

BibTeX
@article{Peng2026,
  author = {Peng, Xinyi and Guo, Genglin and Li, Songyu and Sun, Songyao and Ouyang, Cong and Cui, Jiajun},
  title = {ZBTB4 Deficiency Exacerbates DSS-Induced Colitis Through Activating NF-κB Pathway},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {929},
  doi = {10.3390/cells15100929}
}
Kostenlos starten →